CRISPR Therapy at Three Years: What the Follow-Up Data Shows
Gene editing's first approved treatments were celebrated — and expensive. The new long-term data answers the questions the approval headlines couldn't.
Topic
Evidence-based reporting on medicine, sleep, fitness and longevity claims.
Gene editing's first approved treatments were celebrated — and expensive. The new long-term data answers the questions the approval headlines couldn't.
Researchers finally have a working model of the body clock — and it has opinions about your travel schedule. The protocol that survives contact with evidence.
Every year adds thousands of sequenced ancient genomes. The story they tell — of repeated mass movements, plagues and population turnovers — keeps overturning settled history.
Phone-free hotels, analogue weekends and screen Sabbaths: the hospitality industry has discovered boredom as a luxury good. Notes from three days without a feed.
The cities that made cycling mainstream did not sell exercise. They built something ordinary people would choose at 8 a.m. in the rain. The recipe, extracted.
Districts built gaming labs expecting a distraction magnet. Instead they got a new pipeline to college scholarships — and a generation of students learning teamwork in lobbies.